Importantly, LCar and LW6 administration could improve iBAT thermogenesis of aging mice via regulating ACar metabolism, suggesting that the Sirt3/HIF1α axis and ACar metabolism in BACs might be a potential therapeutic target for aging related metabolic disorder. This evidence concerns the gene HIF1A and metabolic disease.